SG Americas Securities
RCEL icon

SG Americas Securities’s Avita Medical RCEL Stock Holding History

SG Americas Securities’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,823
Closed -$190K – 3703
2024
Q4 		$190K Buy
+14,823
New +$175K ﹤0.01% 2208
2021
Q4 		– Sell
-9,308
Closed -$165K – 3736
2021
Q3 		$165K Buy
+9,308
New +$176K ﹤0.01% 3356

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SG Americas Securities's RCEL Position: Q1 2025 in Review

SG Americas Securities sold out of Avita Medical (RCEL) in Q1 2025, closing a stake of 14,823 shares — an estimated $190K sold.

SG Americas Securities first reported a position in RCEL in Q3 2021 and held it in 2 quarters. The position peaked at $190K in Q4 2024. 74 funds tracked by Wall St. Rank hold RCEL as of Q1 2025.

  • SG Americas Securities reported no remaining Avita Medical position as of Q1 2025 after selling out during the quarter.
  • SG Americas Securities sold 14,823 Avita Medical shares in Q1 2025, an estimated $190K.
  • SG Americas Securities first reported a position in Avita Medical in Q3 2021 and held it in 2 quarters.
  • SG Americas Securities's Avita Medical position peaked at $190K in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q1 2025.

Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.